Yet funding is only part of the equation. Microbiome science does not fit neatly within a single discipline or institution, and no single lab or cancer center can answer these questions alone. Advancing discoveries into clinical trials — and ultimately into standard care — requires coordination among research institutions, healthcare systems, government and philanthropy.

This effort also means untangling years of siloed work: sharing standards, building interoperable data systems and committing to long-term evidence generation. The infrastructure required will need to extend far beyond individual institutional priorities. Patients, too, must be willing to participate in clinical trials, and all stakeholders must share a commitment to understanding the biology within us.

The challenge is not a lack of scientific talent. It is the willingness to invest — and to bring great minds and communities together.